211 related articles for article (PubMed ID: 9534838)
1. Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF). Remission despite continuous treatment with clozapine.
Sperner-Unterweger B; Czeipek I; Gaggl S; Geissler D; Spiel G; Fleischhacker WW
Br J Psychiatry; 1998 Jan; 172():82-4. PubMed ID: 9534838
[TBL] [Abstract][Full Text] [Related]
2. Use of cytokines in clozapine-induced agranulocytosis.
Chin-Yee I; Bezchlibnyk-Butler K; Wong L
Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
[TBL] [Abstract][Full Text] [Related]
3. Clozapine and granulocyte colony-stimulating factor: potential for long-term combination treatment for clozapine-induced neutropenia.
Mathewson KA; Lindenmayer JP
J Clin Psychopharmacol; 2007 Dec; 27(6):714-5. PubMed ID: 18004146
[No Abstract] [Full Text] [Related]
4. The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review.
Lally J; Malik S; Krivoy A; Whiskey E; Taylor DM; Gaughran FP; Flanagan RJ; Mijovic A; MacCabe JH
J Clin Psychopharmacol; 2017 Oct; 37(5):600-604. PubMed ID: 28817489
[TBL] [Abstract][Full Text] [Related]
5. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
Simon L; Cazard F
Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
[TBL] [Abstract][Full Text] [Related]
6. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
Myles N; Myles H; Clark SR; Bird R; Siskind D
Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065
[TBL] [Abstract][Full Text] [Related]
7. Successful Use of Single Doses of Granulocyte-Colony Stimulating Factor (G-CSF) in the Treatment of Late-Onset Agranulocytosis Associated With Clozapine in a Patient With Treatment-Resistant Schizophrenia: A Case Report.
Comacchio C; Dusi N; Lasalvia A
J Clin Psychopharmacol; 2016 Apr; 36(2):173-4. PubMed ID: 26859277
[No Abstract] [Full Text] [Related]
8. Increased apoptosis of neutrophils in a case of clozapine-induced agranulocytosis - a case report.
Loeffler S; Fehsel K; Henning U; Fischer J; Agelink M; Kolb-Bachofen V; Klimke A
Pharmacopsychiatry; 2003 Jan; 36(1):37-41. PubMed ID: 12649775
[TBL] [Abstract][Full Text] [Related]
9. Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine.
Kolli V; Denton K; Borra D; Pulluri M; Sharma A
Psychooncology; 2013 Jul; 22(7):1674-5. PubMed ID: 23059755
[TBL] [Abstract][Full Text] [Related]
10. G-CSF plasma levels in clozapine-induced neutropenia.
Jauss M; Pantel J; Werle E; Schröder J
Biol Psychiatry; 2000 Dec; 48(11):1113-5. PubMed ID: 11094146
[TBL] [Abstract][Full Text] [Related]
11. Clozapine re-challenge under the cover of Filgrastim.
Gopalakrishnan R; Subhalakshmi TP; Kuruvilla A; Jacob KS
J Postgrad Med; 2013; 59(1):54-5. PubMed ID: 23525060
[TBL] [Abstract][Full Text] [Related]
12. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
Lertxundi U; Sanchez P; Hernandez R; Elizagarate E
J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
[No Abstract] [Full Text] [Related]
13. Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia.
Rajagopal G; Graham JG; Haut FF
J Intellect Disabil Res; 2007 Jan; 51(Pt 1):82-5. PubMed ID: 17181606
[TBL] [Abstract][Full Text] [Related]
14. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
Hazewinkel AW; Bogers JP; Giltay EJ
Gen Hosp Psychiatry; 2013; 35(5):576.e11-2. PubMed ID: 23395419
[TBL] [Abstract][Full Text] [Related]
15. Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
Béchard L; Corbeil O; Plante M; Thivierge MA; Lafrenière CÉ; Roy MA; Demers MF
J Psychopharmacol; 2021 Sep; 35(9):1152-1157. PubMed ID: 34229529
[TBL] [Abstract][Full Text] [Related]
16. As-Required Filgrastim for Late-Onset Neutropenia Complicating Long-Term Clozapine Treatment: a Case Report.
Chan KSW; Lai NBW; Wong MMC; Pang PF
East Asian Arch Psychiatry; 2023 Mar; 33(1):28-31. PubMed ID: 36991553
[TBL] [Abstract][Full Text] [Related]
17. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH
J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
[TBL] [Abstract][Full Text] [Related]
18. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
Whiskey E; Taylor D
CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
[TBL] [Abstract][Full Text] [Related]
19. Late-onset clozapine-induced agranulocytosis in a patient with comorbid multiple sclerosis.
Raveendranathan D; Sharma E; Venkatasubramanian G; Rao MG; Varambally S; Gangadhar BN
Gen Hosp Psychiatry; 2013; 35(5):574.e5-6. PubMed ID: 22902258
[TBL] [Abstract][Full Text] [Related]
20. Morning pseudoneutropenia during clozapine treatment.
Esposito D; Aouillé J; Rouillon F; Limosin F
World J Biol Psychiatry; 2003 Oct; 4(4):192-4. PubMed ID: 14608591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
